Stay updated on INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.

Latest updates to the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe urothelial carcinoma trial record is now available instead of an error page, with detailed study design, participant criteria, locations, outcome measures, and record history. It also includes study documents and drug/device information.SummaryDifference59%

- Check20 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA notice about NIH website terminology changes appears above the ClinicalTrials.gov error page. The study record remains inaccessible.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer's ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check62 days agoChange DetectedA 403 Forbidden page now appears where the study record should be, with the site chrome visible but no study content, placing the page in an error state instead of displaying details.SummaryDifference19%

Stay in the know with updates to INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.